NEW YORK, Feb. 4, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of buyers of Sarepta Therapeutics, Inc. ("Sarepta" or...
SRPT
The MarketWatch News Office was not concerned in the development of this articles. SAN DIEGO, Jan 12, 2021 (World NEWSWIRE...
